Variant report
Variant | nsv554395 |
---|---|
Chromosome Location | chr11:50008258-50642550 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:1151)
- CpG islands (count:2381)
- Chromatin interactive region (count:4)
- LncRNA region (count:50)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr11:50017185-50017430 | HepG2 | liver: | n/a | n/a |
2 | ATF1 | chr11:50409411-50409611 | K562 | blood: | n/a | n/a |
3 | ATF1 | chr11:50381201-50381204 | K562 | blood: | n/a | n/a |
4 | ATF1 | chr11:50257555-50257921 | K562 | blood: | n/a | n/a |
5 | ATF3 | chr11:50257564-50257818 | K562 | blood: | n/a | chr11:50257726-50257746 chr11:50257724-50257737 chr11:50257584-50257592 chr11:50257723-50257738 chr11:50257725-50257736 |
6 | BATF | chr11:50251866-50252053 | GM12878 | blood: | n/a | n/a |
7 | BHLHE40 | chr11:50609960-50609990 | GM12878 | blood: | n/a | n/a |
8 | BHLHE40 | chr11:50017239-50017377 | K562 | blood: | n/a | n/a |
9 | BHLHE40 | chr11:50257408-50257634 | K562 | blood: | n/a | chr11:50257599-50257615 |
10 | BRCA1 | chr11:50609964-50609989 | GM12878 | blood: | n/a | n/a |
11 | CBX3 | chr11:50017158-50017392 | K562 | blood: | n/a | n/a |
12 | CBX3 | chr11:50017099-50017442 | K562 | blood: | n/a | n/a |
13 | CCNT2 | chr11:50134957-50135155 | K562 | blood: | n/a | n/a |
14 | CCNT2 | chr11:50257299-50257888 | K562 | blood: | n/a | n/a |
15 | CEBPB | chr11:50114607-50115033 | MCF-7 | breast: | n/a | chr11:50114830-50114843 chr11:50114830-50114843 chr11:50114832-50114841 chr11:50114830-50114841 chr11:50114832-50114843 |
16 | CEBPB | chr11:50114776-50115008 | Hela-S3 | cervix: | n/a | chr11:50114830-50114843 chr11:50114830-50114843 chr11:50114832-50114841 chr11:50114830-50114841 chr11:50114832-50114843 |
17 | CEBPB | chr11:50132343-50132599 | HepG2 | liver: | n/a | n/a |
18 | CEBPB | chr11:50202172-50202422 | IMR90 | lung: | n/a | chr11:50202284-50202295 |
19 | CEBPB | chr11:50105602-50105814 | IMR90 | lung: | n/a | n/a |
20 | CEBPB | chr11:50114681-50114996 | HepG2 | liver: | n/a | chr11:50114830-50114843 chr11:50114830-50114843 chr11:50114832-50114841 chr11:50114830-50114841 chr11:50114832-50114843 |
21 | CEBPB | chr11:50230060-50230405 | MCF-7 | breast: | n/a | n/a |
22 | CEBPB | chr11:50182673-50182737 | HepG2 | liver: | n/a | chr11:50182687-50182698 |
23 | CEBPB | chr11:50134957-50135324 | H1-hESC | embryonic stem cell: | n/a | n/a |
24 | CEBPB | chr11:50062165-50062194 | HepG2 | liver: | n/a | chr11:50062170-50062183 chr11:50062171-50062182 chr11:50062170-50062183 |
25 | CEBPB | chr11:50256020-50256220 | HepG2 | liver: | n/a | chr11:50256104-50256115 |
26 | CEBPB | chr11:50185206-50185319 | A549 | lung: | n/a | chr11:50185257-50185274 chr11:50185258-50185271 chr11:50185259-50185270 chr11:50185258-50185269 |
27 | CEBPB | chr11:50202142-50202359 | HepG2 | liver: | n/a | chr11:50202284-50202295 |
28 | CEBPB | chr11:50062636-50062814 | HepG2 | liver: | n/a | chr11:50062715-50062726 |
29 | CEBPB | chr11:50132313-50132582 | IMR90 | lung: | n/a | n/a |
30 | CEBPB | chr11:50056041-50056226 | HepG2 | liver: | n/a | chr11:50056106-50056117 |
31 | CEBPB | chr11:50180269-50180536 | MCF-7 | breast: | n/a | n/a |
32 | CEBPB | chr11:50185114-50185392 | HepG2 | liver: | n/a | chr11:50185257-50185274 chr11:50185258-50185271 chr11:50185259-50185270 chr11:50185258-50185269 |
33 | CEBPB | chr11:50256005-50256238 | K562 | blood: | n/a | chr11:50256104-50256115 |
34 | CEBPB | chr11:50114701-50115022 | MCF-7 | breast: | n/a | chr11:50114830-50114843 chr11:50114830-50114843 chr11:50114832-50114841 chr11:50114830-50114841 chr11:50114832-50114843 |
35 | CEBPB | chr11:50145990-50146140 | HepG2 | liver: | n/a | chr11:50146064-50146075 |
36 | CEBPB | chr11:50409463-50409610 | H1-hESC | embryonic stem cell: | n/a | n/a |
37 | CEBPB | chr11:50233638-50233794 | HepG2 | liver: | n/a | n/a |
38 | CEBPB | chr11:50114752-50114922 | K562 | blood: | n/a | chr11:50114830-50114843 chr11:50114830-50114843 chr11:50114832-50114841 chr11:50114830-50114841 chr11:50114832-50114843 |
39 | CEBPB | chr11:50114658-50114986 | IMR90 | lung: | n/a | chr11:50114830-50114843 chr11:50114830-50114843 chr11:50114832-50114841 chr11:50114830-50114841 chr11:50114832-50114843 |
40 | CEBPB | chr11:50114698-50115007 | A549 | lung: | n/a | chr11:50114830-50114843 chr11:50114830-50114843 chr11:50114832-50114841 chr11:50114830-50114841 chr11:50114832-50114843 |
41 | CEBPB | chr11:50047487-50047664 | A549 | lung: | n/a | n/a |
42 | CHD1 | chr11:50409410-50409777 | H1-hESC | embryonic stem cell: | n/a | n/a |
43 | CHD1 | chr11:50382847-50382977 | GM12878 | blood: | n/a | n/a |
44 | CHD1 | chr11:50609964-50609986 | GM12878 | blood: | n/a | n/a |
45 | CHD1 | chr11:50134958-50135158 | H1-hESC | embryonic stem cell: | n/a | n/a |
46 | CHD2 | chr11:50522282-50522663 | Hela-S3 | cervix: | n/a | n/a |
47 | CHD2 | chr11:50614701-50614706 | HepG2 | liver: | n/a | n/a |
48 | CHD2 | chr11:50491957-50491986 | Hela-S3 | cervix: | n/a | n/a |
49 | CHD2 | chr11:50609872-50609989 | GM12878 | blood: | n/a | n/a |
50 | CHD2 | chr11:50017167-50017356 | K562 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:50257625-50257675 | GM19239 | blood: | n/a |
2 | chr11:50227265-50227315 | Caco-2 | colon: | n/a |
3 | chr11:50257625-50257675 | GM19239 | blood: | n/a |
4 | chr11:50227265-50227315 | Caco-2 | colon: | n/a |
5 | chr11:50236153-50236203 | GM12878 | blood: | n/a |
6 | chr11:50219952-50220002 | NB4 | blood: | n/a |
7 | chr11:50220343-50220393 | ProgFib | skin: | n/a |
8 | chr11:50219952-50220002 | RPTEC | kidney: | n/a |
9 | chr11:50260762-50260812 | HCF | heart: | n/a |
10 | chr11:50206530-50206580 | MCF-7 | breast: | n/a |
11 | chr11:50220055-50220105 | HNPCEpiC | eye: | n/a |
12 | chr11:50239550-50239600 | NB4 | blood: | n/a |
13 | chr11:50220343-50220393 | PANC-1 | pancreas: | n/a |
14 | chr11:50257633-50257683 | NB4 | blood: | n/a |
15 | chr11:50254503-50254553 | HAEpiC | amniotic membrane: | n/a |
16 | chr11:50219952-50220002 | AG09319 | gingival: | n/a |
17 | chr11:50257496-50257546 | MCF-7 | breast: | n/a |
18 | chr11:50220343-50220393 | SAEC | small airway: | n/a |
19 | chr11:50227476-50227526 | ProgFib | skin: | n/a |
20 | chr11:50227265-50227315 | SK-N-SH_RA | brain: | n/a |
21 | chr11:50238009-50238059 | HIPEpiC | eye: | n/a |
22 | chr11:50227265-50227315 | SK-N-SH | brain: | n/a |
23 | chr11:50257496-50257546 | U87 | brain: | n/a |
24 | chr11:50371681-50371731 | MCF-7 | breast: | n/a |
25 | chr11:50239550-50239600 | ProgFib | skin: | n/a |
26 | chr11:50234973-50235023 | AG04449 | skin: | fetal |
27 | chr11:50226789-50226839 | HRE | kidney: | n/a |
28 | chr11:50231261-50231311 | GM12891 | blood: | n/a |
29 | chr11:50257752-50257802 | AoSMC | blood vessel: | n/a |
30 | chr11:50256574-50256624 | NB4 | blood: | n/a |
31 | chr11:50238107-50238157 | ProgFib | skin: | n/a |
32 | chr11:50257752-50257802 | A549 | lung: | n/a |
33 | chr11:50239550-50239600 | ECC-1 | luminal epithelium: | n/a |
34 | chr11:50227199-50227249 | NHDF-neo | bronchial: | n/a |
35 | chr11:50220426-50220476 | SK-N-SH | brain: | n/a |
36 | chr11:50206606-50206656 | HRPEpiC | eye: | n/a |
37 | chr11:50227476-50227526 | HRE | kidney: | n/a |
38 | chr11:50257256-50257306 | CMK | blood: | n/a |
39 | chr11:50227199-50227249 | PFSK-1 | brain: | n/a |
40 | chr11:50257771-50257821 | LNCaP | prostate: | n/a |
41 | chr11:50368251-50368301 | SK-N-SH_RA | brain: | n/a |
42 | chr11:50236153-50236203 | NB4 | blood: | n/a |
43 | chr11:50258750-50258800 | BE2_C | brain: | n/a |
44 | chr11:50220389-50220439 | HIPEpiC | eye: | n/a |
45 | chr11:50227102-50227152 | RPTEC | kidney: | n/a |
46 | chr11:50227199-50227249 | NH-A | brain: | n/a |
47 | chr11:50257752-50257802 | PANC-1 | pancreas: | n/a |
48 | chr11:50257752-50257802 | SK-N-MC | brain: | n/a |
49 | chr11:50258750-50258800 | NHDF-neo | bronchial: | n/a |
50 | chr11:50206561-50206611 | ProgFib | skin: | n/a |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:50172306..50174473-chr11:50176469..50178865,2 | K562 | blood: | |
2 | chr11:49547545..49548055-chr11:50016701..50017446,2 | MCF-7 | breast: | |
3 | chr11:50172306..50174473-chr11:50176469..50178865,2 | K562 | blood: | |
4 | chr11:50256839..50259422-chr11:50261676..50263683,2 | K562 | blood: |
(count:50 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-OR4C13-9 | chr11:50376439-50376850 | NONHSAT021344 |
2 | lnc-OR4C12-2 | chr11:50060063-50060146 | NONHSAT021327 |
3 | lnc-OR4C13-7 | chr11:50280085-50280169 | NONHSAT021339 |
4 | lnc-OR4C13-1 | chr11:50261115-50261299 | NONHSAT021336 |
5 | lnc-OR4C13-7 | chr11:50279538-50279677 | NONHSAT021339 |
6 | lnc-OR4C13-9 | chr11:50379313-50379548 | NR_024504 |
7 | lnc-OR4C13-7 | chr11:50302810-50302996 | NONHSAT021339 |
8 | lnc-OR4C13-7 | chr11:50274586-50274767 | NONHSAT021339 |
9 | lnc-OR4C13-7 | chr11:50266852-50266898 | NONHSAT021340 |
10 | lnc-OR4C13-1 | chr11:50262310-50262433 | ENSG00000254518 |
11 | lnc-OR4C13-9 | chr11:50378065-50378165 | NONHSAT021344 |
12 | lnc-OR4C13-1 | chr11:50262310-50262433 | NONHSAT021336 |
13 | lnc-OR4C13-9 | chr11:50368318-50368359 | NR_024504 |
14 | lnc-OR4C13-7 | chr11:50266792-50266965 | NONHSAT021338 |
15 | lnc-OR4C13-7 | chr11:50279839-50280169 | NONHSAT021342 |
16 | lnc-OR4C13-9 | chr11:50379313-50379548 | NONHSAT021345 |
17 | lnc-OR4C13-1 | chr11:50261115-50261299 | ENSG00000254518 |
18 | lnc-OR4C13-7 | chr11:50320143-50320239 | NONHSAT021340 |
19 | lnc-OR4C13-9 | chr11:50379775-50379803 | NONHSAT021345 |
20 | lnc-OR4C13-7 | chr11:50320710-50320877 | NONHSAT021340 |
21 | lnc-OR4C13-7 | chr11:50274586-50274778 | NONHSAT021338 |
22 | lnc-OR4C13-9 | chr11:50379775-50379802 | NR_024504 |
23 | lnc-OR4C13-7 | chr11:50313156-50313246 | NONHSAT021340 |
24 | lnc-OR4C13-9 | chr11:50378065-50378165 | NONHSAT021345 |
25 | lnc-OR4C13-1 | chr11:50263752-50263827 | ENSG00000254518 |
26 | lnc-OR4C13-9 | chr11:50376439-50376850 | NONHSAT021345 |
27 | lnc-OR4C12-1 | chr11:50232840-50233106 | XLOC_009440 |
28 | lnc-OR4C13-7 | chr11:50266792-50266898 | NONHSAT021339 |
29 | lnc-OR4C12-1 | chr11:50231598-50231759 | XLOC_009440 |
30 | lnc-OR4C13-1 | chr11:50257789-50258088 | ENSG00000254518 |
31 | lnc-OR4C13-9 | chr11:50375235-50375391 | NONHSAT021345 |
32 | lnc-OR4C12-2 | chr11:50060551-50060604 | NONHSAT021327 |
33 | lnc-OR4C13-9 | chr11:50368739-50368821 | NR_024504 |
34 | lnc-OR4C13-9 | chr11:50379313-50379802 | NONHSAT021344 |
35 | lnc-OR4C13-9 | chr11:50375274-50375391 | NR_024504 |
36 | lnc-OR4C13-7 | chr11:50280085-50280169 | NONHSAT021340 |
37 | lnc-OR4C13-7 | chr11:50302810-50303035 | NONHSAT021343 |
38 | lnc-OR4C13-1 | chr11:50263752-50263827 | NONHSAT021336 |
39 | lnc-OR4C13-7 | chr11:50302810-50303098 | NONHSAT021342 |
40 | lnc-OR4C12-2 | chr11:50061788-50062069 | NONHSAT021327 |
41 | lnc-OR4C13-7 | chr11:50301870-50302020 | NONHSAT021343 |
42 | lnc-OR4C13-1 | chr11:50257750-50258210 | NONHSAT021336 |
43 | lnc-OR4C13-1 | chr11:50257750-50258088 | ENSG00000254518 |
44 | lnc-OR4C13-9 | chr11:50378065-50378165 | NR_024504 |
45 | lnc-OR4C13-9 | chr11:50375235-50375391 | NONHSAT021344 |
46 | lnc-OR4C13-7 | chr11:50301079-50301142 | NONHSAT021343 |
47 | lnc-OR4C13-9 | chr11:50368739-50368821 | NONHSAT021344 |
48 | lnc-OR4C13-7 | chr11:50279538-50279677 | NONHSAT021340 |
49 | lnc-OR4C13-9 | chr11:50368318-50368359 | NONHSAT021344 |
50 | lnc-OR4C13-7 | chr11:50274586-50274767 | NONHSAT021340 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000255500 | TF binding region |
ENSG00000254840 | TF binding region |
ENSG00000255199 | TF binding region |
ENSG00000255001 | TF binding region |
ENSG00000255442 | TF binding region |
ENSG00000254518 | TF binding region |
ENSG00000255042 | TF binding region |
OR4C12 | TF binding region |
ENSG00000236919 | TF binding region |
ENSG00000214883 | TF binding region |
ENSG00000255500 | CpG island |
ENSG00000254840 | CpG island |
ENSG00000255199 | CpG island |
ENSG00000255001 | CpG island |
ENSG00000255442 | CpG island |
ENSG00000254518 | CpG island |
ENSG00000255042 | CpG island |
OR4C12 | CpG island |
ENSG00000236919 | CpG island |
ENSG00000214883 | CpG island |
ENSG00000254518 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs190262285 | chr11:50039211-50039212 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs182395209 | chr11:50039237-50039238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs574678132 | chr11:50039258-50039259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs530988689 | chr11:50039279-50039280 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs201831370 | chr11:50039358-50039359 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs75388644 | chr11:50039359-50039360 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs28411228 | chr11:50039363-50039364 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs202163031 | chr11:50039365-50039366 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs550798187 | chr11:50039370-50039371 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs187394240 | chr11:50039406-50039407 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs536550079 | chr11:50039458-50039459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs191724797 | chr11:50039463-50039464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs533900234 | chr11:50039491-50039492 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs150370720 | chr11:50039505-50039506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs566288066 | chr11:50039513-50039514 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs145024458 | chr11:50039531-50039532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs149076744 | chr11:50039534-50039535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs113087310 | chr11:50039540-50039541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs372280135 | chr11:50039586-50039587 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs375111677 | chr11:50039605-50039606 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs183956652 | chr11:50039623-50039624 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs574740277 | chr11:50039669-50039670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs371587437 | chr11:50039704-50039705 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs144696986 | chr11:50039710-50039711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs558073432 | chr11:50039744-50039745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs554199140 | chr11:50039774-50039775 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs28560250 | chr11:50039796-50039797 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs138555056 | chr11:50039811-50039812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs28430465 | chr11:50039832-50039833 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs189205635 | chr11:50039886-50039887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs374841346 | chr11:50039916-50039917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs141540656 | chr11:50039945-50039946 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs117728889 | chr11:50040018-50040019 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs561155459 | chr11:50040019-50040020 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs557463314 | chr11:50040034-50040035 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs376614794 | chr11:50040041-50040042 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs530291992 | chr11:50040047-50040048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs547000293 | chr11:50040060-50040061 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs567180552 | chr11:50040082-50040083 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs574160623 | chr11:50040091-50040092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs193061800 | chr11:50040092-50040093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs552580120 | chr11:50040106-50040107 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs569372781 | chr11:50040138-50040139 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs183968129 | chr11:50040142-50040143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs28417656 | chr11:50040152-50040153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs72920451 | chr11:50040153-50040154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs377746771 | chr11:50040154-50040155 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs71455954 | chr11:50040155-50040156 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs145553208 | chr11:50040158-50040159 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs142874265 | chr11:50040166-50040167 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Wilms tumour | 21544195 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Potocki-Shaffer syndrome | 19222835 | CNVD |
WAGR syndrome | 19222835 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Colorectal cancer | 21128281 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21990379 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Schizophrenia | 23813976 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Mortal | 21835882 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Autism | 22495309 | CNVD |
Melanoma | 20877625 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 17142309 | CNVD |
Bipolar disorder | 19214233 | CNVD |
Medulloblastoma | 21163964 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:50039200-50040600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr11:50040600-50049200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr11:50047400-50047600 | ZNF genes & repeats | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr11:50049200-50049600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr11:50049600-50054400 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr11:50054400-50058600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
7 | chr11:50056000-50056400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
8 | chr11:50057400-50058000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
9 | chr11:50066200-50067400 | ZNF genes & repeats | iPS-20b Cell Line | embryonic stem cell |
10 | chr11:50100600-50101400 | Enhancers | Adipose Nuclei | Adipose |
11 | chr11:50101400-50103600 | Weak transcription | Adipose Nuclei | Adipose |
12 | chr11:50103200-50103400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
13 | chr11:50103600-50103800 | Enhancers | Adipose Nuclei | Adipose |
14 | chr11:50103600-50105200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
15 | chr11:50105200-50106400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
16 | chr11:50114800-50115200 | Enhancers | Adipose Nuclei | Adipose |
17 | chr11:50129000-50130400 | ZNF genes & repeats | Placenta | Placenta |
18 | chr11:50129400-50129800 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
19 | chr11:50130400-50131000 | Active TSS | Placenta | Placenta |
20 | chr11:50133000-50133200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
21 | chr11:50133000-50133800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
22 | chr11:50133200-50133600 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
23 | chr11:50133200-50134200 | Flanking Active TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
24 | chr11:50133200-50134400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
25 | chr11:50133200-50134400 | Enhancers | Adipose Nuclei | Adipose |
26 | chr11:50133600-50133800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
27 | chr11:50133800-50134000 | Flanking Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
28 | chr11:50133800-50134000 | Flanking Active TSS | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
29 | chr11:50134000-50134400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
30 | chr11:50134000-50135000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
31 | chr11:50134200-50134400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
32 | chr11:50134400-50140400 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
33 | chr11:50134400-50146200 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
34 | chr11:50136600-50136800 | ZNF genes & repeats | HUES64 Cell Line | embryonic stem cell |
35 | chr11:50140400-50142200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
36 | chr11:50140400-50142600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
37 | chr11:50141800-50142000 | Weak transcription | Adipose Nuclei | Adipose |
38 | chr11:50142000-50142200 | Enhancers | Adipose Nuclei | Adipose |
39 | chr11:50142200-50144600 | Weak transcription | Adipose Nuclei | Adipose |
40 | chr11:50142200-50145600 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
41 | chr11:50142600-50147000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
42 | chr11:50144600-50147200 | Enhancers | Adipose Nuclei | Adipose |
43 | chr11:50145600-50146000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
44 | chr11:50145800-50147400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
45 | chr11:50146000-50147000 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
46 | chr11:50146200-50147400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
47 | chr11:50147000-50147400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
48 | chr11:50147000-50147600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
49 | chr11:50151800-50152200 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
50 | chr11:50155000-50155200 | Active TSS | HMEC | breast |